Related Experiment Video

Updated: May 13, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Targeted therapy in melanoma

Ragini R Kudchadkar1, Keiran S M Smalley, L Frank Glass

  • 1Department of Cutaneous Oncology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.

Clinics in Dermatology
|February 27, 2013
PubMed

Insights

Targeted therapies, including BRAF inhibitors, have advanced melanoma treatment. This review covers BRAF/MEK/ERK pathway signaling, resistance, and managing skin toxicities from these melanoma drugs.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Activating BRAF oncogene mutations drive melanoma progression.
  • Targeted therapies offer new treatment avenues for advanced melanoma.
  • Understanding BRAF/MEK/ERK pathway is crucial for melanoma treatment.

Purpose of the Study:

  • Review recent advancements in targeted melanoma therapies.
  • Explore BRAF pathway inhibitors and resistance mechanisms.
  • Discuss management of dermatologic toxicities associated with melanoma treatments.

Main Methods:

  • Literature review of BRAF/MEK/ERK pathway signaling in melanoma.
  • Analysis of targeted drug development for melanoma mutations (NRAS, KIT, GNAQ, GNA11).
  • Examination of clinical strategies for BRAF inhibitor resistance and skin toxicities.

Main Results:

  • BRAF inhibitors show efficacy in metastatic melanoma.
  • BRAF inhibitor resistance is a significant clinical challenge.
  • Targeted therapies cause various skin toxicities requiring management.

Conclusions:

  • Targeted therapies have transformed melanoma treatment.
  • Combination therapies are key to overcoming BRAF inhibitor resistance.
  • Managing dermatologic side effects is essential for patients receiving melanoma targeted therapy.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...